News Release Details
Entegris Reports Strong First-Quarter Results
First-quarter sales were
Quarterly Financial Results Summary
(in thousands, except per share data)
GAAP Results |
Q1-2017 |
Q1-2016 |
Q4-2016 | |||
Net sales |
|
|
| |||
Operating income |
|
|
| |||
Operating margin |
16.0% |
11.1% |
14.6% | |||
Net income |
|
|
| |||
Diluted earnings per share (EPS) |
|
|
| |||
Non-GAAP Results | ||||||
Non-GAAP adjusted operating income |
|
|
| |||
Adjusted operating margin |
19.5 % |
15.3% |
18.1% | |||
Non-GAAP net income |
|
|
| |||
Non-GAAP EPS |
|
|
|
Second-Quarter Outlook
For the second quarter ending
Segment Results
As of
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases, and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
First-Quarter Results Conference Call Details
Management's slide presentation concerning the results for the first quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.
ABOUT
Non-GAAP Information
The Company's condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Forward-Looking Statements
Certain information contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current management expectations only as of the date of this press release, and involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Statements that include such words as "anticipate," "believe," "estimate," "expect," "forecast," "may," "will," "should" or the negative thereof and similar expressions as they relate to
| |||||||
Three months ended | |||||||
|
|
| |||||
Net sales |
|
|
| ||||
Cost of sales |
177,781 |
152,318 |
176,702 | ||||
Gross profit |
139,596 |
114,706 |
131,800 | ||||
Selling, general and administrative expenses |
50,492 |
47,956 |
48,734 | ||||
Engineering, research and development expenses |
27,239 |
25,902 |
27,223 | ||||
Amortization of intangible assets |
10,945 |
11,289 |
10,938 | ||||
Operating income |
50,920 |
29,559 |
44,905 | ||||
Interest expense, net |
8,393 |
9,149 |
8,983 | ||||
Other expense (income), net |
902 |
(675) |
1,303 | ||||
Income before income tax expense |
41,625 |
21,085 |
34,619 | ||||
Income tax expense |
9,111 |
4,873 |
8,521 | ||||
Net income |
|
|
| ||||
Basic net income per common share: |
|
|
| ||||
Diluted net income per common share: |
|
|
| ||||
Weighted average shares outstanding: |
|||||||
Basic |
141,501 |
140,780 |
141,315 | ||||
Diluted |
143,315 |
141,371 |
142,631 |
| ||||
|
| |||
ASSETS |
||||
Cash and cash equivalents |
|
| ||
Accounts receivable, net |
176,032 |
165,675 | ||
Inventories |
188,343 |
183,529 | ||
Deferred tax charges and refundable income taxes |
16,729 |
20,140 | ||
Other current assets |
19,489 |
24,398 | ||
Total current assets |
791,752 |
800,131 | ||
Property, plant and equipment, net |
330,926 |
321,562 | ||
|
349,120 |
345,269 | ||
Intangible assets |
208,591 |
217,548 | ||
Deferred tax assets |
8,418 |
8,022 | ||
Other assets |
7,287 |
7,000 | ||
Total assets |
|
| ||
LIABILITIES AND SHAREHOLDERS' EQUITY |
||||
Long-term debt, current maturities |
|
| ||
Accounts payable |
54,516 |
61,617 | ||
Accrued liabilities |
66,382 |
83,530 | ||
Income tax payable |
15,341 |
16,424 | ||
Total current liabilities |
236,239 |
261,571 | ||
Long-term debt, excluding current maturities |
460,315 |
484,677 | ||
Other liabilities |
54,479 |
54,066 | ||
Shareholders' equity |
945,061 |
899,218 | ||
Total liabilities and shareholders' equity |
|
|
| ||||
Three months ended | ||||
|
| |||
Operating activities: |
||||
Net income |
|
|
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
13,977 |
13,700 |
||
Amortization |
10,945 |
11,289 |
||
Stock-based compensation expense |
3,870 |
2,861 |
||
Provision for deferred income taxes |
3,422 |
(211) |
||
Other |
3,633 |
4,796 |
||
Changes in operating assets and liabilities: |
||||
Trade accounts and notes receivable |
(7,546) |
(6,799) |
||
Inventories |
(5,415) |
(12,998) |
||
Accounts payable and accrued liabilities |
(23,490) |
(9,510) |
||
Income taxes payable and refundable income taxes |
(1,252) |
(726) |
||
Other |
2,774 |
(1,275) |
||
Net cash provided by operating activities |
33,432 |
17,339 |
||
Investing activities: |
||||
Acquisition of property and equipment |
(22,190) |
(17,819) |
||
Other |
186 |
(2,495) |
||
Net cash used in investing activities |
(22,004) |
(20,314) |
||
Financing activities: |
||||
Payments on long-term debt |
(25,000) |
— |
||
Issuance of common stock |
1,041 |
— |
||
Taxes paid related to net share settlement of equity awards |
(4,575) |
(2,067) |
||
Other |
(4,270) |
(3,524) |
||
Net cash used in financing activities |
(32,804) |
(5,591) |
||
Effect of exchange rate changes on cash |
6,146 |
3,144 |
||
Decrease in cash and cash equivalents |
(15,230) |
(5,422) |
||
Cash and cash equivalents at beginning of period |
406,389 |
349,825 |
||
Cash and cash equivalents at end of period |
|
|
| ||||||
Three months ended | ||||||
Net sales |
|
|
| |||
Specialty Chemicals and Engineered Materials |
|
|
| |||
Microcontamination Control |
100,055 |
77,619 |
98,717 | |||
Advanced Materials Handling |
102,887 |
88,298 |
98,840 | |||
Total net sales |
|
|
|
Three months ended | ||||||
Segment profit |
|
|
| |||
Specialty Chemicals and Engineered Materials |
|
|
| |||
Microcontamination Control |
35,581 |
18,140 |
31,719 | |||
Advanced Materials Handling |
18,276 |
18,911 |
16,644 | |||
Total segment profit |
81,997 |
59,467 |
74,282 | |||
Amortization of intangibles |
10,945 |
11,289 |
10,938 | |||
Unallocated expenses |
20,132 |
18,619 |
18,439 | |||
Total operating income |
|
|
|
| ||||||
Three months ended | ||||||
|
|
| ||||
Net sales |
|
|
| |||
Net income |
|
|
| |||
Adjustments to net income: |
||||||
Income tax expense |
9,111 |
4,873 |
8,521 | |||
Interest expense, net |
8,393 |
9,149 |
8,983 | |||
Other expense (income), net |
902 |
(675) |
1,303 | |||
GAAP - Operating income |
50,920 |
29,559 |
44,905 | |||
Amortization of intangible assets |
10,945 |
11,289 |
10,938 | |||
Adjusted operating income |
61,865 |
40,848 |
55,843 | |||
Depreciation |
13,977 |
13,700 |
14,303 | |||
Adjusted EBITDA |
|
|
| |||
Adjusted operating margin |
19.5% |
15.3% |
18.1% | |||
Adjusted EBITDA - as a % of net sales |
23.9% |
20.4% |
22.7% |
| ||||||
Three months ended | ||||||
|
|
| ||||
GAAP net income |
|
|
| |||
Adjustments to net income: |
||||||
Gain on sale of equity investment |
— |
(118) |
— | |||
Amortization of intangible assets |
10,945 |
11,289 |
10,938 | |||
Tax effect of adjustments to net income and discrete items |
(2,705) |
(3,766) |
(2,742) | |||
Non-GAAP net income |
|
|
| |||
Diluted earnings per common share |
|
|
| |||
Effect of adjustments to net income |
|
|
| |||
Diluted non-GAAP earnings per common share |
|
|
|
Contact:
VP of Corporate Relations
T + 978 436 6500
irelations@entegris.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/entegris-reports-strong-first-quarter-results-300446862.html
SOURCE
News Provided by Acquire Media